Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	99.5	88.1	75.61	94.32	89.6	223.3
Short-Term Investments	158.1	150.23	145.82	108.89	113.3	120.51
Cash & Short-Term Investments	257.6	238.33	221.43	203.2	202.89	343.81
Cash Growth	4.97%	7.63%	8.97%	0.15%	-40.99%	56.39%
Accounts Receivable	9,051	8,299	7,512	7,046	8,648	7,499
Other Receivables	-	227.03	188.21	47.17	39.11	6.98
Receivables	9,063	8,533	7,708	7,095	8,691	7,506
Inventory	6,031	4,908	4,729	4,859	5,163	5,259
Other Current Assets	1,222	998.86	725.3	1,050	861.42	824.5
Total Current Assets	16,574	14,678	13,384	13,207	14,918	13,934
Property, Plant & Equipment	13,323	11,914	11,331	10,351	8,622	7,665
Long-Term Investments	275.5	273.11	224.13	199.74	187.99	194.8
Other Intangible Assets	162.4	1,088	631.88	368.24	243.34	1.53
Other Long-Term Assets	202.1	199.66	176.19	197.04	242.33	284.36
Total Assets	30,537	28,153	25,747	24,324	24,214	22,080

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	4,985	4,939	4,339	4,496	4,925	4,687
Accrued Expenses	134.2	99.05	67.22	71.78	91.65	76.77
Short-Term Debt	-	-	-	-	3,605	3,563
Current Portion of Long-Term Debt	3,791	3,180	3,282	2,871	412.96	435
Current Portion of Leases	7.7	9.47	11.78	9.5	19.92	25.97
Current Income Taxes Payable	215.2	71.48	-	11.81	42.33	-
Other Current Liabilities	1,303	924.41	668.88	495.39	397.13	612.7
Total Current Liabilities	10,436	9,223	8,370	7,955	9,495	9,401
Long-Term Debt	2,395	2,569	2,840	2,753	2,047	1,385
Long-Term Leases	2.4	8.6	16.51	9.14	4.03	18.79
Long-Term Unearned Revenue	2.5	2.32	1.6	1.7	1.7	1.7
Pension & Post-Retirement Benefits	45.5	-	-	27.41	30.35	28.75
Long-Term Deferred Tax Liabilities	839	812.66	782.33	757.07	709.68	724.31
Other Long-Term Liabilities	0.11	45.55	43.25	-0	-	157.45
Total Liabilities	13,720	12,660	12,053	11,504	12,287	11,717

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	912.7	912.7	912.7	919.35	926	926
Retained Earnings	-	14,327	12,560	11,701	10,811	9,240
Comprehensive Income & Other	15,903	249.3	217.31	194.75	187.48	197.4
Total Common Equity	16,816	15,489	13,690	12,815	11,924	10,364
Minority Interest	1.49	3.65	3.44	4.06	2.33	-0.6
Shareholders' Equity	16,817	15,492	13,693	12,820	11,927	10,363
Total Liabilities & Equity	30,537	28,153	25,747	24,324	24,214	22,080

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	6,196	5,766	6,151	5,643	6,089	5,428
Net Cash (Debt)	-5,939	-5,528	-5,929	-5,440	-5,886	-5,084
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-65.07	-60.57	-64.96	-59.17	-63.57	-54.91
Filing Date Shares Outstanding	91.27	91.27	91.27	91.94	92.6	92.6
Total Common Shares Outstanding	91.27	91.27	91.27	91.94	92.6	92.6
Working Capital	6,138	5,455	5,014	5,252	5,423	4,533
Book Value Per Share	184.24	169.70	149.99	139.40	128.77	111.92
Tangible Book Value	16,653	14,401	13,058	12,447	11,681	10,362
Tangible Book Value Per Share	182.46	157.78	143.07	135.39	126.14	111.90
Land	-	948.11	948.11	937.67	937.67	934.6
Buildings	-	2,961	2,419	2,257	1,932	1,921
Machinery	-	13,654	11,463	10,633	9,122	8,792
Construction In Progress	-	1,215	2,741	2,252	1,868	767.37

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error